74999-36-3 Usage
Explanation
Different sources of media describe the Explanation of 74999-36-3 differently. You can refer to the following data:
1. The compound has a total of 8 carbon atoms, 11 hydrogen atoms, 1 nitrogen atom, and 2 oxygen atoms in its structure.
2. Heterocyclic compound
2. The compound contains a pyrrole ring, which is a five-membered ring with one nitrogen atom, making it a heterocyclic compound.
3. Methyl ester derivative
3. The compound is derived from 1H-pyrrole-2-carboxylic acid by attaching a methyl ester group to the carboxylic acid functional group.
4. Natural occurrence
4. This chemical is commonly found in various natural products, indicating that it is a component of some substances occurring in nature.
5. Pharmaceutical applications
5. The compound has potential applications in the pharmaceutical industry, particularly in the synthesis of drugs and biologically active compounds.
6. Organic synthesis building block
6. It is used as a building block in organic synthesis, which means it can be used to create more complex molecules through chemical reactions.
7. Industrial uses
7. The compound may have other industrial uses, although specific applications are not mentioned in the provided material.
8. Health risks
8. Caution should be exercised when handling this compound, as it may pose health risks if not managed properly. This could include potential toxicity, irritancy, or other hazardous properties.
Check Digit Verification of cas no
The CAS Registry Mumber 74999-36-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,9,9 and 9 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 74999-36:
(7*7)+(6*4)+(5*9)+(4*9)+(3*9)+(2*3)+(1*6)=193
193 % 10 = 3
So 74999-36-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H11NO2/c1-5-4-6(2)9-7(5)8(10)11-3/h4,9H,1-3H3
74999-36-3Relevant articles and documents
ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS
-
Paragraph 0415, (2021/10/22)
The invention provides compounds of Formula (I): as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections.
13C-labeled bilirubin: Synthesis of 31(3 2),171(172)-di-[13C]-mesobilirubin- XIIIα
Boiadjiev, Stefan E.,Lightner, David A.
scheme or table, p. 111 - 119 (2010/06/20)
The title compound, labeled with 13C in the ethyl groups was synthesized from K13CN and low-molecular-weight components. The synthetic relay compound was 31(32)[13C]- xanthobilirubinic acid methyl ester in a synthetic route that leads to a label in the ethyl β-substituent of a dipyrrinone model for bilirubin. This labeled dipyrrinone was oxidatively coupled to the dimethyl ester of mesobiliverdin-XIIIα, thereby providing a route to a 13C- labeled mesobiliverdin and mesobilirubin, with one carbon of each ethyl being 98% 13C-enriched.
Synthesis of cyanopyrroles
Cheng, Lingjiang,Lightner, David A.
, p. 46 - 48 (2007/10/03)
Regioselective synthesis of α-cyanopyrroles (vs. α- alkoxycarbonylpyrroles) using oximinocyanoacetate esters in a Knorr-type reductive condensation with β-diketones can be directed by the presence of water. Thus, methyl oximinocyanoacetate was reacted with pentane-2,4-dione in hot acetic acid in the presence of zinc dust to give exclusively 3,5- dimethylpyrrole-2-carbonitrile when the acetic acid was wet; whereas, in glacial acetic acid only methyl 3,5-dimethylpyrrole-2-carboxylate was isolated (~40% yield).
